Ipca Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ipca Laboratories has informed exchanges about a scheduled Board meeting on May 29, 2026. The meeting agenda includes consideration and approval of Standalone and Consolidated Audited Financial Results for Q4 and FY ended March 31, 2026, along with recommendation of Dividend for FY 2025-26. The company also reminded that the trading window for insiders remains closed from April 1, 2026 until 48 hours after the results declaration (till May 31, 2026). This is a routine regulatory intimation filed under SEBI LODR regulations.
This is a standard pre-result announcement notice. No immediate impact on stock price as actual financial results and dividend details will be disclosed after the board meeting on May 29, 2026.